Walmart settles federal lawsuit over role in opioid epidemic - The Journal Record
Walmart settles a federal lawsuit related to its role in the opioid epidemic, impacting the regulatory landscape for pharmacies.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on September 3, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Medium urgency. Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies. should confirm how it applies to their specific situation before acting. There is a time constraint attached: Not specified.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Increased scrutiny on opioid dispensing practices and potential changes in compliance requirements for pharmacies.
Who it affects
Independent pharmacies, retail chains, compounding pharmacies, and long-term-care pharmacies.
What you must do
Review and possibly update opioid dispensing protocols and compliance measures to align with heightened regulatory expectations.
Deadline
Not specified.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- New Maine law recognizes pharmacists as health care providers - une.edu
- Florida pharmacists receive approval to provide COVID-19 vaccines - wusf.org
- Express Scripts Launches Court Fight on Arkansas Pharmacy Law - news.bloomberglaw.com
- Determination That PHENAPHEN WITH CODEINE NO. 3 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 30 Milligrams, and PHENAPHEN WITH CODEINE NO. 4 (Acetaminophen; Codeine Phosphate) Oral Capsules, 325 Milligrams and 60 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness
- Pharmacies may violate civil rights if they refuse meds linked to abortion, feds warn - NPR